Robert G. Savage, Director at EPICEPT CORP (EPCT), bought 6,500 shares at $1.57 ($10K) on 2007-08-20, disclosed to the SEC on 2007-08-21.
Open-market purchase of $10k EPCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.57 | 500 | $785 | 7.7% |
| 2 | $1.57 | 1,000 | $2K | 15.3% |
| 3 | $1.57 | 1,100 | $2K | 16.8% |
| 4 | $1.58 | 800 | $1K | 12.3% |
| 5 | $1.58 | 900 | $1K | 13.9% |
| 6 | $1.58 | 500 |
| $790 |
| 7.7% |
| 7 | $1.58 | 700 | $1K | 10.8% |
| 8 | $1.59 | 1,000 | $2K | 15.5% |
| Total | $1.58 avg | 6,500 | $10K | 100% |
| Filing → |
| EPCT | BUY | 2007-08-20 | $6K | — | Filing → |